BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+4.07%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$155M
AUM Growth
+$155M
Cap. Flow
+$10.2M
Cap. Flow %
6.61%
Top 10 Hldgs %
70.21%
Holding
70
New
6
Increased
8
Reduced
5
Closed
3

Top Buys

1
ELUT icon
Elutia
ELUT
$8.06M
2
INBX
Inhibrx, Inc. Common Stock
INBX
$1.75M
3
BDSX icon
Biodesix
BDSX
$782K
4
NBIX icon
Neurocrine Biosciences
NBIX
$767K
5
TSVT
2seventy bio
TSVT
$718K

Top Sells

1
BMY icon
Bristol-Myers Squibb
BMY
$1.87M
2
XLRN
Acceleron Pharma Inc.
XLRN
$1.84M
3
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
$410K
4
VNDA icon
Vanda Pharmaceuticals
VNDA
$314K
5
ARQT icon
Arcutis Biotherapeutics
ARQT
$215K

Sector Composition

1 Healthcare 96.09%
2 Energy 2.08%
3 Consumer Staples 0.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$96B
$47.8M 30.8% 766,106 -30,000 -4% -$1.87M
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$11.7M 7.57% 2,252,388 – –
ELUT icon
3
Elutia
ELUT
$96.7M
$8.35M 5.39% 1,417,923 +1,367,923 +2,736% +$8.06M
QDEL icon
4
QuidelOrtho
QDEL
$1.95B
$8.06M 5.2% 59,684 – –
NBIX icon
5
Neurocrine Biosciences
NBIX
$13.8B
$7.6M 4.9% 89,200 +9,000 +11% +$767K
FHTX icon
6
Foghorn Therapeutics
FHTX
$286M
$7.18M 4.63% 314,143 – –
BDSX icon
7
Biodesix
BDSX
$62.6M
$6.63M 4.27% 1,252,753 +147,800 +13% +$782K
ACAD icon
8
Acadia Pharmaceuticals
ACAD
$4.38B
$4.65M 3% 199,400 – –
UTHR icon
9
United Therapeutics
UTHR
$13.8B
$3.89M 2.51% 18,000 – –
BIIB icon
10
Biogen
BIIB
$19.4B
$3.02M 1.95% 12,600 – –
ALBO
11
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$2.63M 1.7% 113,000 – –
MASI icon
12
Masimo
MASI
$7.59B
$2.34M 1.51% 8,000 – –
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.05M 1.32% 22,000 – –
PRTA icon
14
Prothena Corp
PRTA
$441M
$1.99M 1.28% 40,247 – –
INBX
15
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.75M 1.13% +40,000 New +$1.75M
CLR
16
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.73M 1.11% 38,600 – –
BHVN
17
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.65M 1.07% 12,000 +2,000 +20% +$276K
KPTI icon
18
Karyopharm Therapeutics
KPTI
$61.7M
$1.58M 1.02% 246,000 – –
HROW icon
19
Harrow
HROW
$1.44B
$1.56M 1% 180,000 – –
IMGN
20
DELISTED
Immunogen Inc
IMGN
$1.41M 0.91% 190,000 – –
ETRN
21
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$1.38M 0.89% 133,050 – –
NKTR icon
22
Nektar Therapeutics
NKTR
$568M
$1.35M 0.87% 100,000 +28,000 +39% +$378K
PTGX icon
23
Protagonist Therapeutics
PTGX
$3.67B
$1.3M 0.84% 38,000 – –
ARVN icon
24
Arvinas
ARVN
$568M
$1.23M 0.79% 15,000 – –
ALKS icon
25
Alkermes
ALKS
$4.78B
$1.16M 0.75% 50,000 – –
1
2 3